We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

AlphaTON Capital Corp.

Company price
None USD 0.00(0%)
Last update at 2026-11-12T15:42:08.199943Z
Market Cap
7.50M

Momentum Score

…

AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.22
Low
13.80
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on AlphaTON Capital Corp. (NASDAQ: ATON) is limited, and its core business and strategy are not clearly disclosed in widely available filings. Because detailed drivers are not documented publicly, investors should review the company's regulatory filings to understand potential long-term growth sources. The stock may offer access to a listed investment vehicle but this requires confirmation of strategy, fees and manager track record.
Principal risks include limited transparency and disclosure, manager and execution risk, potential leverage and liquidity constraints, and governance issues common to externally managed investment vehicles.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
0.01
ROE
-311.00%
Net Debt
-1.67M
ROCE
-602.49%
Diluted EPS TTM
-8.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax -6.78M -85.70M -122.52M -14.82M -14.89M
Minority interest 0.01M 0.04M 0.06M 2.30M -
Net income -6.77M -75.34M -104.61M -16.87M -15.83M
Selling general administrative 4.25M 5.66M 8.36M 8.82M 5.13M
Gross profit -0.04M -0.05M -0.00M - -
Reconciled depreciation 0.04M 0.05M 0.00M 0.00M -
Ebit -6.78M -18.25M -122.25M -30.30M -26.43M
Ebitda -6.74M -18.20M -122.25M -14.77M -14.71M
Depreciation and amortization 0.04M 0.05M 0.00M 15.59M 12.24M
Operating income -7.42M -18.25M -16.58M -15.59M -12.44M
Other operating expenses 7.42M 18.25M 16.58M 15.59M 12.44M
Interest expense 0.00M 0.03M 0.01M 0.04M 0.18M
Tax provision -0.00M -10.55M -17.86M 4.35M -
Interest income 0.09M 0.27M 0.22M 0.00M -
Net interest income 0.09M 0.24M 0.21M -0.04M -
Income tax expense -0.00M -10.55M -17.86M 4.35M 2.30M
Total revenue 0.00M 0.00M 0.00M 0.00M -
Total operating expenses 7.38M 18.20M 16.57M 15.59M 12.44M
Cost of revenue 0.04M 0.05M 0.00M - -
Total other income expense net 0.64M -67.44M -105.95M 0.77M -2.45M
Net income from continuing ops -6.78M -75.38M -104.67M -19.17M -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 2.23M 7.78M 99.13M 194.66M 174.86M
Intangible assets - - 81.68M 117.39M 117.39M
Other current assets 0.54M 2.63M 2.45M 1.27M 1.49M
Total liab 3.05M 4.45M 23.73M 29.23M 27.26M
Total stockholder equity -0.12M 4.02M 76.05M 121.20M 101.45M
Other current liab 0.67M 2.36M 1.59M 0.59M 2.94M
Common stock 221.80M 219.50M 218.78M 158.32M 130.65M
Capital stock 221.80M 219.50M 218.78M 158.32M -
Retained earnings -245.45M -239.32M -159.62M -55.01M -38.13M
Good will - - 0.00M 43.32M 43.32M
Cash 1.67M 5.03M 10.54M 23.35M 2.77M
Total current liabilities 1.10M 2.88M 1.86M 0.78M 3.21M
Net debt -1.67M -4.98M -10.54M -23.35M -2.62M
Short term debt - 0.04M - - 0.15M
Short long term debt total - 0.05M - - 0.15M
Other stockholder equity - - - 16.93M 7.98M
Total current assets 2.23M 7.70M 13.68M 24.83M 4.95M
Long term investments - 0.00M 2.89M 9.08M -
Net receivables 0.01M 0.04M 0.68M 0.21M 0.68M
Accounts payable 0.43M 0.48M 0.27M 0.19M 0.11M
Accumulated other comprehensive income 23.53M 23.84M 16.88M 0.96M 0.96M
Non currrent assets other - 0.05M 0.88M 0.04M 0.06M
Non current assets total 0.00M 0.08M 85.45M 169.83M 169.91M
Capital lease obligations 0.00M 0.05M 0.00M - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments 0.00M 2.81M -0.62M 0.00M -
Total cashflows from investing activities - 2.81M -0.62M - -0.86M
Net borrowings -0.05M -0.04M -2.00M 0.00M -
Total cash from financing activities 2.10M 5.97M -0.12M 27.35M 4.76M
Net income -6.78M -75.34M -104.67M -19.17M -17.19M
Change in cash -3.36M -5.52M -12.81M 20.58M -0.38M
Begin period cash flow 5.03M 10.54M 23.35M 2.77M 3.15M
End period cash flow 1.67M 5.03M 10.54M 23.35M 2.77M
Total cash from operating activities -5.46M -14.30M -12.07M -6.76M -4.28M
Issuance of capital stock 2.15M 6.03M 2.98M 29.09M -
Depreciation 0.04M 0.05M 0.00M 0.00M 1.02M
Other cashflows from investing activities - - -0.61M - -0.00M
Change to inventory - - - 1.21M -0.88M
Change to account receivables 1.57M -0.03M -0.03M 0.52M -0.11M
Other cashflows from financing activities 0.00M -0.02M -1.10M -1.75M -1.25M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 1.00M
Change in working capital 1.52M 0.98M -0.01M -0.46M -0.74M
Stock based compensation 0.32M 0.00M 4.28M 9.14M 8.83M
Other non cash items -0.56M 70.57M 106.21M -0.67M 1.36M
Free cash flow -5.46M -14.30M -12.08M -6.76M -3.28M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BLK
BlackRock Inc
2.63
0.21%
1228.94 26.25 19.57 6.33 2.90 6.35 17.13
BX
Blackstone Group Inc
-1.80
1.48%
120.20 33.20 20.12 11.05 11.56 9.14 15.74
IVSBF
Investor AB ser. B
0.01
0.01%
43.59 4.67 3.83 3.78 1.13 4.15 1.68
KKR
KKR & Co. Inc.
-1.70
1.70%
98.35 32.68 13.66 3.58 3.22 0.68 1.47

Profile*

AlphaTON Capital Corp.

AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentralized finance protocols, gaming platforms, and business applications. The company is also advancing various therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The company was formerly known as Portage Biotech Inc. and changed its name to AlphaTON Capital Corp. in September 2025. AlphaTON Capital Corp. is based in Road Town, British Virgin Islands.

Clarence Thomas Building, Road Town, British Virgin Islands, VG1110

302 219 5556

3

Name Title Year Born
Dr. Robert A. Kramer Ph.D. Chief Scientific Officer 1952
Mr. Fiorenzo A. Villani Executive Chairman & Chief Investment Officer 1971
Ms. Brittany Kaiser CEO & Director 1989
Mr. Wesley Allen Levitt C.F.A. Chief Financial Officer 1988
Mr. Logan Ryan Golema Chief Technology Officer NA
Mr. William De'Ath Chief Partnership Officer NA
Adam Melero Controller NA
Mr. Peter Molloy Chief Executive Officer of Cyncado Therapeutics Inc. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…